120 related articles for article (PubMed ID: 10377723)
1. [Pramipexol: a new dopaminergic agonist for the treatment of Parkinson disease].
Grandas F; Galiano ML
Neurologia; 1999 May; 14(5):224-8. PubMed ID: 10377723
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
Dooley M; Markham A
Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical studies of pramipexole: clinical relevance.
Hubble JP
Eur J Neurol; 2000 May; 7 Suppl 1():15-20. PubMed ID: 11054154
[TBL] [Abstract][Full Text] [Related]
4. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
Bennett JP; Piercey MF
J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Parkinson's disease should begin with a dopamine agonist.
Montastruc JL; Rascol O; Senard JM
Mov Disord; 1999 Sep; 14(5):725-30. PubMed ID: 10495032
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.
Piercey MF
Clin Neuropharmacol; 1998; 21(3):141-51. PubMed ID: 9617505
[TBL] [Abstract][Full Text] [Related]
7. Combination of two different dopamine agonists in the management of Parkinson's disease.
Stocchi F; Berardelli A; Vacca L; Thomas A; De Pandis MF; Modugno N; Valente M; Ruggieri S
Neurol Sci; 2002 Sep; 23 Suppl 2():S115-6. PubMed ID: 12548370
[TBL] [Abstract][Full Text] [Related]
8. New pharmacotherapy for Parkinson's disease.
Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK
Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of dopamine agonists.
Lam YW
Pharmacotherapy; 2000 Jan; 20(1 Pt 2):17S-25S. PubMed ID: 10641988
[TBL] [Abstract][Full Text] [Related]
10. The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa.
MacMahon DG
Age Ageing; 2003 May; 32(3):244-5. PubMed ID: 12720606
[No Abstract] [Full Text] [Related]
11. DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S93-7. PubMed ID: 12211148
[No Abstract] [Full Text] [Related]
12. Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.
Inzelberg R; Schechtman E; Nisipeanu P
Drugs Aging; 2003; 20(11):847-55. PubMed ID: 12964891
[TBL] [Abstract][Full Text] [Related]
13. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Grosset K; Needleman F; Macphee G; Grosset D
Mov Disord; 2004 Nov; 19(11):1370-4. PubMed ID: 15389984
[TBL] [Abstract][Full Text] [Related]
14. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
Linazasoro G;
J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
[TBL] [Abstract][Full Text] [Related]
15. [Choosing a dopamine agonist in Parkinson's disease].
Bogucki A; Gajos A
Neurol Neurochir Pol; 2007; 41(2 Suppl 1):S14-21. PubMed ID: 17941454
[TBL] [Abstract][Full Text] [Related]
16. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
Künig G; Pogarell O; Möller JC; Delf M; Oertel WH
Clin Neuropharmacol; 1999; 22(5):301-5. PubMed ID: 10516884
[TBL] [Abstract][Full Text] [Related]
17. An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease.
Pinter MM; Rutgers AW; Hebenstreit E
J Neural Transm (Vienna); 2000; 107(11):1307-23. PubMed ID: 11145006
[TBL] [Abstract][Full Text] [Related]
18. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
Molho ES; Factor SA; Weiner WJ; Sanchez-Ramos JR; Singer C; Shulman L; Brown D; Sheldon C
J Neural Transm Suppl; 1995; 45():225-30. PubMed ID: 8748629
[TBL] [Abstract][Full Text] [Related]
19. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.
Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G
Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263
[TBL] [Abstract][Full Text] [Related]
20. Slowing Parkinson's disease progression: recent dopamine agonist trials.
Montgomery EB
Neurology; 2004 Jan; 62(2):343; author reply 343-5. PubMed ID: 14745094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
